DeeptiSatelliMD
Oncology • Kansas City, MOAssistant Professor. Oncology . University Of Kansas health system
Dr. Satelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 N Green Hills Rd
Kansas City, MO 64154Phone+1 913-574-2520Fax+1 913-574-2612
Education & Training
University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016- University of Kansas School of MedicineResidency, Internal Medicine, 2009 - 2012
Gandhi Medical CollegeClass of 2006
Certifications & Licensure
KS State Medical License 2012 - 2025
MO State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 28 citationsClinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial.Priyanka Sharma, Shane R Stecklein, Rachel Yoder, Joshua M Staley, Kelsey Schwensen
JAMA Oncology. 2024-02-01 - 49 citationsRandomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer...Priyanka Sharma, Bruce F. Kimler, Anne O'Dea, Lauren Nye, Yen Y. Wang
Clinical Cancer Research. 2021-02-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
